|
|
|
|
| LEADER |
00923nab a2200253 i 4500 |
| 001 |
publ13597 |
| 005 |
20180706142514.0 |
| 008 |
180706s2015 hu o 0|| zxx d |
| 022 |
|
|
|a 0163-7258
|
| 024 |
7 |
|
|a 10.1016/j.pharmthera.2015.06.005
|2 doi
|
| 024 |
7 |
|
|a 2907838
|2 mtmt
|
| 040 |
|
|
|a SZTE Publicatio Repozitórium
|b hun
|
| 041 |
|
|
|a zxx
|
| 100 |
1 |
|
|a Schulz Rainer
|
| 245 |
1 |
0 |
|a Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection
|h [elektronikus dokumentum] /
|c Schulz Rainer
|
| 260 |
|
|
|c 2015
|
| 300 |
|
|
|a 90-106
|
| 490 |
0 |
|
|a Pharmacology & Therapeutics
|v 153
|
| 700 |
0 |
1 |
|a Görge Philipp Maximilian
|e aut
|
| 700 |
0 |
1 |
|a Görbe Anikó
|e aut
|
| 700 |
0 |
1 |
|a Ferdinandy Péter
|e aut
|
| 700 |
0 |
1 |
|a Lampe Paul D.
|e aut
|
| 700 |
0 |
1 |
|a Leybaert Luc
|e aut
|
| 856 |
4 |
0 |
|u http://publicatio.bibl.u-szeged.hu/13597/1/Schulz_PharmacholTherapeitics%20_2015.pdf
|z Dokumentum-elérés
|